Search clinical trials for: Empagliflozin 10 MG
Total 12682 results
-
Samsung Medical CenterHanmi Pharmaceutical co., ltd.Active, not recruitingCoronary Artery DiseaseKorea, Republic of
-
Bial R&D Investments, S.A.RecruitingParkinson's DiseaseUnited States, Spain, France, Italy, Netherlands, United Kingdom, Germany, Canada, Poland, Portugal, Sweden
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
ShireTerminatedSanfilippo SyndromeNetherlands, United Kingdom
-
MedImmune LLCCompletedRespiratory Syncytial VirusUnited States, South Africa, Chile
-
University of PisaUnknownGlucose Metabolism Disorders | Renal Function DisorderItaly
-
Clinical Nutrition Research Centre, SingaporeNational University Hospital, SingaporeCompletedCardiometabolic RiskSingapore
-
Isfahan University of Medical SciencesCompletedDiabetes MellitusIran, Islamic Republic of
-
Organon and CoCompleted
-
Valenta Pharm JSCCompletedInfluenza, Human | Common Cold | Acute Respiratory InfectionRussian Federation
-
HaEmek Medical Center, IsraelUnknownDistal UreterolithiasisIsrael
-
University Hospital Inselspital, BerneBoehringer Ingelheim; University of BernCompleted
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Phoenicis TherapeuticsNot yet recruitingDystrophic Epidermolysis BullosaUnited States
-
Kanion & Huawe Medicine Co.,LtdTerminated
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
-
Janssen-Cilag International NVCompleted
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedGastric/Gastroesophageal Junction CancerChina
-
Heptares Therapeutics LimitedCompletedHealthy SubjectsUnited Kingdom
-
MedImmune LLCCompletedHealthy SubjectsUnited States
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Breath of Life International Pharma LtdCompleted
-
Cantex PharmaceuticalsRecruiting
-
MedImmune LLCCompletedHealthy VolunteerUnited Kingdom
-
Idorsia Pharmaceuticals Ltd.CompletedHepatic ImpairmentSwitzerland
-
Caliway Biopharmaceuticals Co., Ltd.CompletedA Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease LipomasDercum's DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompletedCytokine Release Syndrome | Covid-19 PneumoniaPakistan
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Vanderbilt University Medical CenterRecruitingObesity | Metabolic SyndromeUnited States
-
Washington University School of MedicineRecruitingEpilepsyUnited States
-
EMSWithdrawnType2 Diabetes Mellitus
-
Brigham and Women's HospitalUnknown
-
BioprojetCompletedParkinson's Disease | Excessive Daytime SleepinessFrance
-
Christian SchulzeBoehringer Ingelheim; Zentrum für Klinische Studien JenaCompletedAcute Decompensated Heart FailureGermany
-
Beni-Suef UniversityRecruiting
-
Eisai Inc.Completed
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
AmtixBio Co., Ltd.Novotech (Australia) Pty LimitedCompleted
-
Janssen Research & Development, LLCCompleted
-
Yokohama City UniversityRecruiting
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Naga P. ChalasaniNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept PharmaceuticalsTerminatedAlcoholic HepatitisUnited States
-
Eisai Inc.CompletedObesityUnited States
-
Seoul National University Bundang HospitalRecruitingDiabetes Type 2Korea, Republic of